The global healthcare industry, a sector defined by its mission to preserve life, finds itself at a...
Treatment Innovations
Introduction The discourse surrounding the use of medical cannabis in mental health has long been trapped in...
The U.S. pharmaceutical ecosystem is currently navigating a period of profound institutional volatility. Following a year marked...
In the landscape of modern drug discovery, the perception of change often lags behind the reality of...
In a significant leap for the molecular diagnostics sector, California-based biotechnology firm Countable Labs has successfully closed...
As the pharmaceutical giant Merck & Co. stares down the inevitable "patent cliff" for its powerhouse cancer...
Traumatic brain injury (TBI) is a silent global epidemic. Every year, an estimated 69 million individuals sustain...
For decades, the pharmacological landscape for treating major depressive disorder (MDD) has been dominated by selective serotonin...
In a development that has sent shockwaves of optimism through the biotechnology sector, Massachusetts-based Replimune announced on...
STOCKHOLM – The European medical technology and in vitro diagnostics (IVD) industry is currently navigating a period...
